How drug coverage policies affect heart failure treatment
Impact of Restrictive Drug Coverage Policies on Heart Failure Care
['FUNDING_OTHER'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-10984164
This study looks at how strict rules about medication coverage affect patients with heart failure who need important medications, aiming to understand how high costs and extra approval steps make it harder for them to get the treatments they need to stay healthy.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10984164 on ClinicalTrials.gov |
What this research studies
This research investigates how restrictive drug coverage policies impact the prescription and adherence to life-saving medications for patients with heart failure with reduced ejection fraction (HFrEF). It aims to identify the barriers caused by high out-of-pocket costs and prior authorization requirements that prevent patients from receiving necessary treatments. By analyzing a large database that includes insurance formulary information, electronic health records, and census data, the study will quantify the effects of these policies on medication adherence and health outcomes. The findings could help inform better practices and policies to improve patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with heart failure with reduced ejection fraction who may be affected by restrictive drug coverage policies.
Not a fit: Patients with heart failure who are not affected by drug coverage policies or those who do not require guideline-recommended medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to essential medications for heart failure patients, potentially reducing preventable deaths.
How similar studies have performed: Previous research has indicated that restrictive drug coverage policies negatively impact medication adherence and patient outcomes, suggesting that this study's approach is grounded in established findings.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MUKHOPADHYAY, AMRITA — NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- Study coordinator: MUKHOPADHYAY, AMRITA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.